Biomedical academic entrepreneurship through the SBIR program:
"This paper considers the U.S. Small Business Innovation research (SBIR) program as a policy fostering academic entrepreneurship. We highlight two main characteristics of the program that make it attractive as an entrepreneurship policy: early-stage financing and scientist involvement in commer...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2005
|
Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
11450 |
Schlagworte: | |
Online-Zugang: | Volltext |
Zusammenfassung: | "This paper considers the U.S. Small Business Innovation research (SBIR) program as a policy fostering academic entrepreneurship. We highlight two main characteristics of the program that make it attractive as an entrepreneurship policy: early-stage financing and scientist involvement in commercialization. Using unique data on NIH supported biomedical researchers, we trace the incidence of biomedical entrepreneurship through SBIR and describe some of the characteristics of these individuals. To explore the importance of early-stage financing and scientist involvement, we complement our individual level data with information on scientist-linked and non-linked SBIR firms. Our results show that the SBIR program is being used as a commercialization channel by academic scientists. Moreover, we find that the firms associated with these scientists perform significantly better than other non-linked SBIR firms in terms of follow-on venture capital funding, SBIR program completion, and patenting"--National Bureau of Economic Research web site. |
Beschreibung: | 36 S. graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000zcb4500 | ||
---|---|---|---|
001 | BV023591559 | ||
003 | DE-604 | ||
005 | 20100312 | ||
007 | t | ||
008 | 051020s2005 xxud||| |||| 00||| eng d | ||
035 | |a (OCoLC)61156568 | ||
035 | |a (DE-599)BVBBV023591559 | ||
040 | |a DE-604 |b ger | ||
041 | 0 | |a eng | |
044 | |a xxu |c XD-US | ||
049 | |a DE-521 |a DE-19 | ||
050 | 0 | |a HB1 | |
100 | 1 | |a Toole, Andrew A. |e Verfasser |0 (DE-588)130298336 |4 aut | |
245 | 1 | 0 | |a Biomedical academic entrepreneurship through the SBIR program |c Andrew A. Toole ; Dirk Czarnitzki |
264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2005 | |
300 | |a 36 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11450 | |
520 | 3 | |a "This paper considers the U.S. Small Business Innovation research (SBIR) program as a policy fostering academic entrepreneurship. We highlight two main characteristics of the program that make it attractive as an entrepreneurship policy: early-stage financing and scientist involvement in commercialization. Using unique data on NIH supported biomedical researchers, we trace the incidence of biomedical entrepreneurship through SBIR and describe some of the characteristics of these individuals. To explore the importance of early-stage financing and scientist involvement, we complement our individual level data with information on scientist-linked and non-linked SBIR firms. Our results show that the SBIR program is being used as a commercialization channel by academic scientists. Moreover, we find that the firms associated with these scientists perform significantly better than other non-linked SBIR firms in terms of follow-on venture capital funding, SBIR program completion, and patenting"--National Bureau of Economic Research web site. | |
610 | 2 | 4 | |a United States. |b Dept. of Energy. |b Small Business Innovation Research Program |
650 | 4 | |a Medical innovations |x Economic aspects |z United States | |
650 | 4 | |a Medical technology |x Economic aspects |z United States | |
651 | 4 | |a USA | |
700 | 1 | |a Czarnitzki, Dirk |e Verfasser |0 (DE-588)121655040 |4 aut | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 11450 |w (DE-604)BV002801238 |9 11450 | |
856 | 4 | 1 | |u http://papers.nber.org/papers/w11450.pdf |z kostenfrei |3 Volltext |
999 | |a oai:aleph.bib-bvb.de:BVB01-016906889 |
Datensatz im Suchindex
_version_ | 1804138249057206272 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Toole, Andrew A. Czarnitzki, Dirk |
author_GND | (DE-588)130298336 (DE-588)121655040 |
author_facet | Toole, Andrew A. Czarnitzki, Dirk |
author_role | aut aut |
author_sort | Toole, Andrew A. |
author_variant | a a t aa aat d c dc |
building | Verbundindex |
bvnumber | BV023591559 |
callnumber-first | H - Social Science |
callnumber-label | HB1 |
callnumber-raw | HB1 |
callnumber-search | HB1 |
callnumber-sort | HB 11 |
callnumber-subject | HB - Economic Theory and Demography |
ctrlnum | (OCoLC)61156568 (DE-599)BVBBV023591559 |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02554nam a2200385zcb4500</leader><controlfield tag="001">BV023591559</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100312 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">051020s2005 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)61156568</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023591559</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">HB1</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Toole, Andrew A.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)130298336</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biomedical academic entrepreneurship through the SBIR program</subfield><subfield code="c">Andrew A. Toole ; Dirk Czarnitzki</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2005</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">36 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11450</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"This paper considers the U.S. Small Business Innovation research (SBIR) program as a policy fostering academic entrepreneurship. We highlight two main characteristics of the program that make it attractive as an entrepreneurship policy: early-stage financing and scientist involvement in commercialization. Using unique data on NIH supported biomedical researchers, we trace the incidence of biomedical entrepreneurship through SBIR and describe some of the characteristics of these individuals. To explore the importance of early-stage financing and scientist involvement, we complement our individual level data with information on scientist-linked and non-linked SBIR firms. Our results show that the SBIR program is being used as a commercialization channel by academic scientists. Moreover, we find that the firms associated with these scientists perform significantly better than other non-linked SBIR firms in terms of follow-on venture capital funding, SBIR program completion, and patenting"--National Bureau of Economic Research web site.</subfield></datafield><datafield tag="610" ind1="2" ind2="4"><subfield code="a">United States.</subfield><subfield code="b">Dept. of Energy.</subfield><subfield code="b">Small Business Innovation Research Program</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical innovations</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical technology</subfield><subfield code="x">Economic aspects</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Czarnitzki, Dirk</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)121655040</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">11450</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">11450</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w11450.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016906889</subfield></datafield></record></collection> |
geographic | USA |
geographic_facet | USA |
id | DE-604.BV023591559 |
illustrated | Illustrated |
index_date | 2024-07-02T22:41:28Z |
indexdate | 2024-07-09T21:25:11Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016906889 |
oclc_num | 61156568 |
open_access_boolean | 1 |
owner | DE-521 DE-19 DE-BY-UBM |
owner_facet | DE-521 DE-19 DE-BY-UBM |
physical | 36 S. graph. Darst. |
publishDate | 2005 |
publishDateSearch | 2005 |
publishDateSort | 2005 |
publisher | National Bureau of Economic Research |
record_format | marc |
series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
spelling | Toole, Andrew A. Verfasser (DE-588)130298336 aut Biomedical academic entrepreneurship through the SBIR program Andrew A. Toole ; Dirk Czarnitzki Cambridge, Mass. National Bureau of Economic Research 2005 36 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11450 "This paper considers the U.S. Small Business Innovation research (SBIR) program as a policy fostering academic entrepreneurship. We highlight two main characteristics of the program that make it attractive as an entrepreneurship policy: early-stage financing and scientist involvement in commercialization. Using unique data on NIH supported biomedical researchers, we trace the incidence of biomedical entrepreneurship through SBIR and describe some of the characteristics of these individuals. To explore the importance of early-stage financing and scientist involvement, we complement our individual level data with information on scientist-linked and non-linked SBIR firms. Our results show that the SBIR program is being used as a commercialization channel by academic scientists. Moreover, we find that the firms associated with these scientists perform significantly better than other non-linked SBIR firms in terms of follow-on venture capital funding, SBIR program completion, and patenting"--National Bureau of Economic Research web site. United States. Dept. of Energy. Small Business Innovation Research Program Medical innovations Economic aspects United States Medical technology Economic aspects United States USA Czarnitzki, Dirk Verfasser (DE-588)121655040 aut Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 11450 (DE-604)BV002801238 11450 http://papers.nber.org/papers/w11450.pdf kostenfrei Volltext |
spellingShingle | Toole, Andrew A. Czarnitzki, Dirk Biomedical academic entrepreneurship through the SBIR program National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series United States. Dept. of Energy. Small Business Innovation Research Program Medical innovations Economic aspects United States Medical technology Economic aspects United States |
title | Biomedical academic entrepreneurship through the SBIR program |
title_auth | Biomedical academic entrepreneurship through the SBIR program |
title_exact_search | Biomedical academic entrepreneurship through the SBIR program |
title_exact_search_txtP | Biomedical academic entrepreneurship through the SBIR program |
title_full | Biomedical academic entrepreneurship through the SBIR program Andrew A. Toole ; Dirk Czarnitzki |
title_fullStr | Biomedical academic entrepreneurship through the SBIR program Andrew A. Toole ; Dirk Czarnitzki |
title_full_unstemmed | Biomedical academic entrepreneurship through the SBIR program Andrew A. Toole ; Dirk Czarnitzki |
title_short | Biomedical academic entrepreneurship through the SBIR program |
title_sort | biomedical academic entrepreneurship through the sbir program |
topic | United States. Dept. of Energy. Small Business Innovation Research Program Medical innovations Economic aspects United States Medical technology Economic aspects United States |
topic_facet | United States. Dept. of Energy. Small Business Innovation Research Program Medical innovations Economic aspects United States Medical technology Economic aspects United States USA |
url | http://papers.nber.org/papers/w11450.pdf |
volume_link | (DE-604)BV002801238 |
work_keys_str_mv | AT tooleandrewa biomedicalacademicentrepreneurshipthroughthesbirprogram AT czarnitzkidirk biomedicalacademicentrepreneurshipthroughthesbirprogram |